Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02765737 · ClinicalTrials.gov registry record · NA
Dehydrated Human Amnion Chorion Membrane (dHACM) vs. Control in the Treatment of Partial Thickness Burns.
A NA study, sponsored by MiMedx Group.
- Terminated
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT02765737: Clinical Trial NA study, sponsored by MiMedx Group.
NCT02765737 is a NA study that was terminated before completion, run by MiMedx Group. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02765737, a NA study, was terminated before completion, sponsored by MiMedx Group.
- TERMINATED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
Multicenter, prospective, randomized, controlled feasibility trial to determine the safety and effectiveness of Dehydrated Human Amnion Chorion Membrane (dHACM) plus Control as compared to Control alone for the treatment of second degree burns (partial thickness burns) as assessed by time to healing and scarring
Primary Outcome
95% epitheliazation as assesses by the investigator
Interventions
- DEVICE Mepilex Ag
- OTHER Dehydrated Human Amnion/Chorion Membrane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2016-04 |
| Est. Completion | 2019-01 |
| Phase | NA |
Why NCT02765737 stopped before completion
NCT02765737 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Mepilex Ag is the first listed.
NCT02765737 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02765737 about?
NCT02765737 is a clinical study titled "Dehydrated Human Amnion Chorion Membrane (dHACM) vs. Control in the Treatment of Partial Thickness Burns.". Multicenter, prospective, randomized, controlled feasibility trial to determine the safety and effectiveness of Dehydrated Human Amnion Chorion Membrane (dHACM) plus Control as compared to Control alone for the treatment of second degree burns (partial thickness burns) as assessed by time to healing...
What is the current status of trial NCT02765737?
This trial is currently terminated. It is a NA study. The enrollment target is 23 participants. The study started on 2016-04. Estimated completion is 2019-01.
What interventions are being tested in trial NCT02765737?
The interventions under investigation include: Mepilex Ag (DEVICE), Dehydrated Human Amnion/Chorion Membrane (OTHER).
Who is sponsoring clinical trial NCT02765737?
This trial is sponsored by MiMedx Group, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02765737's enrollment target sits among peer trials
23 1755th of 2000 higher than 245 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia